Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
Anastasiya Belyaeva,
Louis Cammarata,
Adityanarayanan Radhakrishnan,
Chandler Squires,
Karren Dai Yang,
G. V. Shivashankar and
Caroline Uhler ()
Additional contact information
Anastasiya Belyaeva: Massachusetts Institute of Technology
Louis Cammarata: Harvard University
Adityanarayanan Radhakrishnan: Massachusetts Institute of Technology
Chandler Squires: Massachusetts Institute of Technology
Karren Dai Yang: Massachusetts Institute of Technology
G. V. Shivashankar: ETH Zurich
Caroline Uhler: Massachusetts Institute of Technology
Nature Communications, 2021, vol. 12, issue 1, 1-13
Abstract:
Abstract Given the severity of the SARS-CoV-2 pandemic, a major challenge is to rapidly repurpose existing approved drugs for clinical interventions. While a number of data-driven and experimental approaches have been suggested in the context of drug repurposing, a platform that systematically integrates available transcriptomic, proteomic and structural data is missing. More importantly, given that SARS-CoV-2 pathogenicity is highly age-dependent, it is critical to integrate aging signatures into drug discovery platforms. We here take advantage of large-scale transcriptional drug screens combined with RNA-seq data of the lung epithelium with SARS-CoV-2 infection as well as the aging lung. To identify robust druggable protein targets, we propose a principled causal framework that makes use of multiple data modalities. Our analysis highlights the importance of serine/threonine and tyrosine kinases as potential targets that intersect the SARS-CoV-2 and aging pathways. By integrating transcriptomic, proteomic and structural data that is available for many diseases, our drug discovery platform is broadly applicable. Rigorous in vitro experiments as well as clinical trials are needed to validate the identified candidate drugs.
Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/s41467-021-21056-z Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21056-z
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-021-21056-z
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().